Mutations in PSEN-1 lead to decreased activity and altered glycosylation of acetylcholinesterase, affecting the extent of cholinergic damage in AD patients (Cortés-Gómez et al., 2023). The gene discussed is PSEN1; the disease is Alzheimer disease.